Flavocure Biotech, Inc.

also Clin0 Glioblastoma Multiforme, Multiple Myeloma, AML (ODD)

Flavocure Biotech is focused on discovering and developing novel cancer therapeutics inspired by natural products. Their research centers around identifying and optimizing bioactive compounds from natural sources with potential for therapeutic applications. Flavocure is developing drugs to target various cancers, including pancreatic cancer, glioblastoma, acute myeloid leukemia, and multiple myeloma. Flavocure Biotech’s lead candidate is caflanone, a flavonoid derived from cannabis for the treatment of pancreatic cancer. It targets tumor-associated macrophages and has shown promising results in preclinical studies.

Jobs: